Document is current
Any future updates will be listed below
-
Authors
Stubberud, Anker http://orcid.org/0000-0003-0934-9914
Buse, Dawn C.
Kristoffersen, Espen Saxhaug
Linde, Mattias
Tronvik, Erling
- License Information
-
More Information
Article History
Received: 16 October 2021
Accepted: 1 December 2021
First Online: 20 December 2021
Declarations
:
: Not applicable.
: Not applicable.
: AS is a part-time employee and shareholder of Nordic Brain Tech AS, a company developing a mHealth behavioral migraine intervention; and has a patent mHealth Biofeedback treatment concept for episodic migraine pending and may benefit financially from a license agreement between Nordic Brain Tech AS and NTNU Norwegian University of Science and Technology.DCB has grants from Amgen, the National Headache Foundation and the FDA. She has been a consultant for Amgen/Novartis, Allergan/Abbvie, Lilly, Lundbeck, and Teva. She is on the editorial board of Current Pain and Headache Reports.ESK reports no competing interest.ML is a shareholder of Nordic Brain Tech AS, a company developing a mHealth behavioral migraine intervention; has a patent mHealth Biofeedback treatment concept for episodic migraine pending and may benefit financially from a license agreement between Nordic Brain Tech AS and NTNU Norwegian University of Science and Technology of the same concept.ET is a shareholder of Nordic Brain Tech AS, a company developing a mHealth behavioral migraine intervention; has a patent mHealth Biofeedback treatment concept for episodic migraine pending and may benefit financially from a license agreement between Nordic Brain Tech AS and NTNU Norwegian University of Science and Technology of the same concept. ET has received personal fees for lectures and advisory boards from Lundbeck, Allergan/Abbvie, Roche, TEVA, Novartis, Amgen, Eli-Lilly. He is board member and shareholder of Palion Medical AS.
